<DOC>
	<DOCNO>NCT00801515</DOCNO>
	<brief_summary>This compassionate study provide continue access maraviroc subject complete study A4001029 show clinical benefit . Assessments safety tolerability maraviroc add OBT continue .</brief_summary>
	<brief_title>A Compassionate Access Protocol For Those Patients Who Have Completed A4001029</brief_title>
	<detailed_description />
	<mesh_term>Maraviroc</mesh_term>
	<criteria>Patients complete study A4001029 Canada still derive clinical benefit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Compassionate</keyword>
	<keyword>HIV</keyword>
	<keyword>CCR5</keyword>
</DOC>